Mutations in p53 have been related with resistance to chemotherapy (Lowe et al, 1993) and CRC cells with p53 mutated or disrupted through homologous recombination were less sensitive to 5-FU (O'Connor et al, 1997; Bunz et al, 1999). Here, TP53 is linked to colorectal carcinoma.